|
Tetra Bio-Pharma Announces Closing of Unit Offering /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/ ORLEANS, ON, July 12, 2019 /CNW Telbec/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Corporation") a clinical-stage biopharmaceutical corporation with its primary focus in cannabinoid‑based drug discovery and development (TSXV: TBP) (OTCQB: TBPMF), is pleased to announce it has closed its previously announced short form prospectus offering of units of the Corporation, including the exercise in full of the Agents' (as defined below) over-allotment option. A total of 26,833,332 units (the "Units") of the Corporation were sold at a price of $0.30 per Unit, for aggregate gross proceeds of approximately $8,050,000 (the "Offering"). https://ceo.ca/@newswire/tetra-bio-pharma-announces-closing-… |
|
| aus der Diskussion: | Tetra Biopharma Phase III Produkt kurz vor Markteinführung |
| Autor (Datum des Eintrages): | HeinzBork (12.07.19 17:19:59) |
| Beitrag: | 227 von 309 (ID:61014500) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |